Decorti G, Rosati A, Candussio L, Giraldi T, Bartoli Klugmann F
Department of Biomedical Sciences, University of Trieste, I-34127, Trieste, Italy.
Biochem Pharmacol. 2001 Jan 1;61(1):61-6. doi: 10.1016/s0006-2952(00)00535-9.
LLC-PK(1) is a proximal tubular cell line derived from normal pig kidney which has a structure and function similar to those of renal proximal tubular cells and which expresses baseline levels of P-glycoprotein. We isolated by drug selection a doxorubicin-resistant cell line (LLC-PK(1)/ADR) that exhibited a multidrug-resistant phenotype; this cell line was characterized by reduced intracellular drug concentrations, an increased drug extrusion, and increased expression of a 170-kDa P-glycoprotein detected by Western blot analysis with monoclonal antibody C219. In addition, an increased expression of MDR1 mRNA was seen by reverse transcriptase-polymerase chain reaction. These results suggest that it is possible to induce the overexpression of P-glycoprotein by chronic treatment with doxorubicin in a normal cell line that physiologically expresses low levels of this protein. This multi-resistant cell line could provide an interesting model for studying the role of P-glycoprotein and the consequence of its induction in a normal tissue.
LLC-PK(1)是一种源自正常猪肾的近端肾小管细胞系,其结构和功能与肾近端肾小管细胞相似,且表达基础水平的P-糖蛋白。我们通过药物筛选分离出一种多药耐药的阿霉素耐药细胞系(LLC-PK(1)/ADR);该细胞系的特征为细胞内药物浓度降低、药物外排增加,以及用单克隆抗体C219进行蛋白质印迹分析检测到的170-kDa P-糖蛋白表达增加。此外,通过逆转录聚合酶链反应可见MDR1 mRNA表达增加。这些结果表明,在生理上表达该蛋白水平较低的正常细胞系中,通过阿霉素长期处理有可能诱导P-糖蛋白的过表达。这种多耐药细胞系可为研究P-糖蛋白的作用及其在正常组织中的诱导后果提供一个有趣的模型。